Related Experiment Video
Updated: Jul 9, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer.
Zachary A Hurst1,2, Sandya Liyanarachchi3, Pamela Brock4
1Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
African American thyroid cancer patients may have worse outcomes due to healthcare disparities rather than genetics. Further research is needed on genetic variants influencing cancer risk and cardiovascular events.
Area of Science:
- Genomics
- Oncology
- Cardiovascular Medicine
Background:
- African American (AA) patients with nonmedullary thyroid cancer (NMTC) often have poorer prognoses compared to European Americans (EA).
- This disparity is potentially linked to healthcare access issues and underlying genetic variations.
- Investigating genetic factors in AA NMTC patients is crucial for understanding outcome differences.
Purpose of the Study:
- To analyze the impact of germline and somatic variants on clinical outcomes in African American NMTC patients.
- To identify presumed pathogenic germline or somatic variants (PPGVs/PPSVs) in cancer-related and cardiovascular risk genes.
- To explore the potential role of genetic variants in cancer progression and treatment response.
Main Methods:
- Whole-exome sequencing of germline DNA (blood/normal tissue) and paired tumor DNA from 37 AA NMTC patients.
- Identification of variants with a Combined Annotation Depletion Dependent (CADD) score ≥20 and VarSome Clinical classification of likely pathogenic or pathogenic.
- Analysis of PPGVs/PPSVs in cancer-related genes, cardiovascular risk genes, and their association with African ancestry.
Main Results:
- 17 PPGVs were found in 16 cancer-related genes, with *WRN* being previously linked to NMTC.
- *BRAF* was the most frequent somatic variant (41% of tumors).
- One patient with *ERCC4* PPGV and *TP53* PPSV died from PTC/ATC; *SC5NA*, *GYG1*, *CBS*, *CFTR*, and *SI* PPGVs were noted in cardiovascular risk genes.
Conclusions:
- Most AA-NMTC patients in this cohort had favorable outcomes post-treatment, suggesting healthcare disparities are a primary driver of worse prognoses.
- The clinical significance of PPGVs that may promote *TP53* mutations or predispose to cardiovascular events requires further investigation.
- Integrated analysis of PPGV/PPSV profiles could aid in identifying high-risk NMTC patients needing closer monitoring or proactive interventions.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutations
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

